BREAKING NEWS: Epidiolex, First Non-Synthetic Cannabis Drug, Approved
Big win today for GW Pharma. In a previous post, we discussed GW Pharmaceuticals, the leading developer of cannabis-based pharmaceuticals. Today, the FDA announced the approval of GW Pharmaceutical’s drug Epidiolex (cannabidiol), an oral solution for treatment of seizures associated with two rare forms of epilepsy, Lennox-Gastaut syndrome and... Read more
Cannabis Taxation: Another Day, Another 280E Case (or Two)
On June 13, the U.S. Tax Court issued an opinion regarding the application of IRC §280E. In Alterman v Commissioner of Internal Revenue (“Alterman“) the Court held, yet again, that IRC §280E operates to disallow a cannabis businesses’ tax deductions. A few days later, the Court also issued Loughman vs.... Read more
Oregon Cannabis: The Week that Was
No shortage of cannabis news in Oregon. Here we are a few years into legalization of recreational cannabis sales in Oregon, and it’s never a dull moment. Over the past week or so, there were three significant developments around the state with respect to marijuana law and policy. We... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )